JQDN

General

Fusion Pharmaceuticals Earnings Date And Reports 2024

Di: Stella

When is Amylyx Pharmaceuticals‘ next earnings announcement? View the latest AMLX earnings date, analysts forecasts, earnings history, and conference call transcripts. In March 2024, in San Diego AstraZeneca entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-generation radioconjugates.

When is Kiniksa Pharmaceuticals International’s next earnings announcement? View the latest KNSA earnings date, analysts forecasts, earnings history, and conference call transcripts. According to Fusion Pharmaceuticals ’s latest financial reports and stock price the company’s current number of shares outstanding is 83,775,652. At the end of 2024 the company had When is Ironwood Pharmaceuticals‘ next earnings announcement? View the latest IRWD earnings date, analysts forecasts, earnings history, and conference call transcripts.

Fusion Pharmaceuticals on LinkedIn: Today we announced program updates ...

The Investor Relations website contains information about AbbVie’s business for stockholders, potential investors, and financial analysts. Fusion will present When is NRx Pharmaceuticals next data in a poster presentation at the American Association for Cancer Research (AACR) Annual Meeting being held in San Diego, CA, April 5-10, 2024.

Biomea Fusion Earnings Date and Reports 2025

View real-time Fusion Pharma (FUSN) live share price and historical data, charts, technical analysis, financial reports and other NASDAQ:FUSN stock data today. When is Regeneron Pharmaceuticals‘ next earnings announcement? View the latest REGN earnings date, analysts forecasts, earnings history, and conference call transcripts. Revenue for Fusion Pharmaceuticals (FUSN) Revenue in 2024 (TTM): ₹0.16 Billion According to Fusion Pharmaceuticals ’s latest financial reports the company’s current revenue (TTM ) is

Download Regeneron’s Annual Reports, Proxy Statements, and Environmental, Social and Governance Reports. Fusion Pharmaceuticals Reports First Quarter 2024 Financial Results and Announces Clinical Program Updates Presented interim data from TATCIST trial of FPI-2265 Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision medicines, today

HAMILTON, ON and BOSTON, June 4, 2024/ PRNewswire/– Fusion Pharmaceuticals Inc., a clinical-stage oncology company focused on developing next

Fusion Pharmaceuticals Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. TARRYTOWN, N.Y., Aug. 01, 2024 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced financial results for the second quarter of 2024 and When is Arrowhead Pharmaceuticals‘ next earnings announcement? View the latest ARWR earnings date, analysts forecasts, earnings history, and conference call transcripts.

Industry Trends Pharmaceuticals January 2024 – O2C Lab

When is Cyclacel Pharmaceuticals‘ next earnings announcement? View the latest CYCC earnings date, analysts forecasts, earnings history, and conference call transcripts. The following information was filed by Fusion Pharmaceuticals Inc. (FUSN) on Tuesday, August 10, 2021 as an 8K 2.02 statement, which is an earnings press release

May 9, 2024 Newswire.ca Fusion Pharmaceuticals Reports First Quarter 2024 Financial Results and Announces Clinical Program Updates May 7, 2024 Newswire.ca

When is Conduit Pharmaceuticals‘ next earnings announcement? View the latest CDT earnings date, analysts forecasts, earnings history, and conference call transcripts. Find CDT earnings date analysts forecasts Regeneron’s financial information and download important documents and U.S. Securities and Exchange Commission filings like the Annual Report, Proxy Statement, 10

When is Avadel Pharmaceuticals‘ next earnings announcement? View the latest AVDL earnings date, analysts forecasts, earnings history, and conference call transcripts. Investor focus is likely to be on updates WIRE Bristol Myers Squibb regarding Fusion Pharmaceuticals‘ (FUSN) pipeline candidates on the fourth-quarter conference call. 5 Days 1 Month 3 Months 6 Months 1 Year 5 Years Show Dividends Show Earnings Start date End date

When is Kiora Pharmaceuticals‘ next earnings announcement? View the latest KPRX earnings company had date, analysts forecasts, earnings history, and conference call transcripts.

PRINCETON, N.J.– (BUSINESS WIRE)– Bristol Myers Squibb (NYSE: BMY) today reports results for the fourth quarter and full year of 2024. “We made good progress in Fusion Pharmaceuticals Inc. (FUSN) SEC Filing 10-Q Quarterly Report for the period ending Wednesday, March 31, 2021

When is NRx Pharmaceuticals‘ next earnings announcement? View the latest NRXP earnings date, analysts forecasts, earnings history, and conference call transcripts. When is Structure Therapeutics‘ next earnings announcement? View the latest GPCR earnings date, analysts forecasts, earnings history, and conference call transcripts.

When is Terns Pharmaceuticals‘ next earnings announcement? View the latest TERN earnings date, analysts forecasts, earnings history, and conference call transcripts.

Learn more about Fusion Pharmaceuticals’s company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.